IRIS
POSTORINO, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.645
EU - Europa 2.169
AS - Asia 2.083
SA - Sud America 298
Continente sconosciuto - Info sul continente non disponibili 260
AF - Africa 40
OC - Oceania 5
Totale 20.500
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.565
SG - Singapore 844
IT - Italia 606
CN - Cina 472
DE - Germania 444
RU - Federazione Russa 260
BR - Brasile 245
UA - Ucraina 205
VN - Vietnam 185
HK - Hong Kong 168
BD - Bangladesh 166
IE - Irlanda 144
FR - Francia 104
GB - Regno Unito 101
SE - Svezia 77
FI - Finlandia 72
JP - Giappone 63
CA - Canada 54
KR - Corea 52
IN - India 42
NL - Olanda 37
PL - Polonia 30
ES - Italia 21
AT - Austria 19
ZA - Sudafrica 17
AR - Argentina 15
UZ - Uzbekistan 13
MX - Messico 12
BE - Belgio 10
ID - Indonesia 10
IQ - Iraq 10
PH - Filippine 10
UY - Uruguay 9
EC - Ecuador 8
TR - Turchia 8
CO - Colombia 7
CZ - Repubblica Ceca 7
LT - Lituania 6
MA - Marocco 6
RO - Romania 6
EG - Egitto 5
KE - Kenya 5
KG - Kirghizistan 5
SA - Arabia Saudita 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
CL - Cile 4
DZ - Algeria 4
GT - Guatemala 4
IR - Iran 4
AL - Albania 3
AU - Australia 3
BG - Bulgaria 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
IL - Israele 3
JO - Giordania 3
MY - Malesia 3
PK - Pakistan 3
CR - Costa Rica 2
JM - Giamaica 2
PE - Perù 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
ET - Etiopia 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
Totale 20.244
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.171
Wilmington 3.749
Houston 3.206
Singapore 479
Ashburn 451
Fairfield 445
Chandler 344
Ann Arbor 330
San Jose 283
Beijing 191
Seattle 176
New York 174
Hong Kong 167
Jacksonville 163
Rome 155
Cambridge 150
Dublin 137
Council Bluffs 123
Medford 98
Dearborn 97
Los Angeles 82
Santa Clara 82
Dallas 78
The Dalles 78
Tokyo 56
Ho Chi Minh City 55
Lawrence 46
Buffalo 44
Hanoi 44
Zhengzhou 43
Milan 39
Munich 37
Moscow 34
Orem 34
Lauterbourg 33
San Diego 32
Chicago 30
Phoenix 24
São Paulo 23
Naples 19
Helsinki 18
Menlo Park 18
Atlanta 17
Mülheim 17
Bologna 16
Shanghai 16
Warsaw 16
Montreal 15
Chennai 14
Hefei 14
Toronto 14
Denver 13
Johannesburg 13
London 13
Nuremberg 13
San Francisco 13
Engelhard 12
Frankfurt am Main 12
Redondo Beach 12
Creede 11
Del Norte 11
Stockholm 11
Boardman 10
Brooklyn 10
Nanjing 10
Palo Alto 10
Poplar 10
Amsterdam 9
Bari 9
Brussels 9
Kraków 9
Rio de Janeiro 9
Turku 9
University Park 9
Vienna 9
Center 8
Da Nang 8
Haiphong 8
Kunming 8
Lappeenranta 8
Mountain View 8
North Bergen 8
Porto Alegre 8
Trieste 8
Columbus 7
Falls Church 7
Florence 7
Jakarta 7
Manchester 7
Montevideo 7
New Delhi 7
Norwalk 7
Palermo 7
Belo Horizonte 6
Charlotte 6
Genoa 6
Guangzhou 6
Mumbai 6
Nanchang 6
Nürnberg 6
Totale 16.610
Salva come PNG Salva come JPEG
Nome #
Autodeterminazione e responsabilità sanitaria: le trasfusioni di sangue nei pazienti Testimoni di Geova. 769
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 515
Collection of peripheral progenitor cells: a comparison between Amicus and Cobe-Spectra blood cell separators 513
An allele-specific RT-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemia 507
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord blood and G-CSF mobilized peripheral blood 504
Identification of a potential topoisomerase II “hotspot” DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms 490
Red blood cell depletion of cord blood using hydroxyethylstarch double sedimentation: analysis of 40 cases 477
Central Nervous System Involvement in Adult Acute Lymphoblastic Leukemia: Diagnostic Tools, Prophylaxis, and Therapy. 472
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 471
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia 468
Minimally differentiated acute myeloid leukemia (AML-MO): Comparison of 25 cases with other French-American-British subtypes 465
Clonal evolution in therapy-related neoplasms 462
P-glycoprotein and BCL-2 levels predict outcome in adult acute lymphoblastic leukaemia 452
The therapeutic use of cord blood 448
SEQUENTIAL THERAPY WITH VAPLD AND BORTEZOMIB AS INDUCTION THERAPY FOR MULTIPLE MYELOMA: A PHARMACOLOGIC COMBINATION TO ACHIEVE COMPLETE REMISSION BEFORE STEM CELL MOBILIZATION 446
SEQUENTIAL THERAPY WITH VAD, BORTEZOMIB AND CYCLOPHOSPHAMIDE AS INDUCTION THERAPY FOR MULTIPLE MYELOMA: A SEQUENTIAL PHARMACOLOGIC COMBINATION TO ACHIEVE COMPLETE REMISSIONS BEFORE STEM CELL TRANSPLANTATION 443
A case of oral mycosis fungoides successfully treated by combination of alemtuzumab and chemotherapy 442
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 441
Bowel Ultrasonography for Timely Diagnosis of Intestinal Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation 433
Cytokine removal under hemodiafiltration with endogenous reinfusion in acute kidney injury secondary to angioimmunoblastic T-cell lymphoma: a case report 432
Simultaneous occurrence of BCR/ABL1 and RUNX1/RUNX1T1 in a case of therapy-related acute myeloid leukemia 422
Percutaneus osteoplasty in the treatment of extraspinal painful multiple myeloma lesions. 416
Reduced intensity allogeneic transplantation in primary cutaneous t-cell lymphomas. 412
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia 411
Percutaneous kyphoplasty: indications and technique in the treatment of vertebral fractures from myeloma 409
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 408
Total parenteral nutrition enriched with glutamine and ω-3 fatty acid in adult patients undergoing autologous stem cell transplantation. 406
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature 406
High sensitivity of flow cytometry improves detection of occult leptomeningeal disease in acute lymphoblastic leukemia and lymphoblastic lymphoma 402
Percutaneus osteoplasty in the treatment of extraspinal painful multiple myeloma lesions 395
Treatment of Acute Myeloid Leukemia with 20-30% Bone Marrow Blasts 395
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias 378
Rituximab single agent in age-related Epstein-Barr virus associated B cell disorder complicated by autoimmune anemia and pure red cell aplasia 376
Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell Lymphoma 375
Extensive toxic epidermal necrolysis following brentuximab vedotin administration 374
Reduced-intensity conditioning combined with standard GvHD prophylaxis is tolerable and highly effective for patients with primary cutaneous T-cell lymphomas undergoing allogeneic transplantation in advanced disease stage. 360
Analysis of the expression of adhesion molecules on CD34+ progenitors from bone marrow, umbilical cord and G-CSF stimulated peripheral blood 355
Infections increase the risk of central venous catheter-related thrombosis in adult acute myeloid leukemia. 350
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia 346
Fludarabine, Cytarabine and Gentuzumab Ozogamicin (FLA-GO) as Salvage Therapy and Bridge to Transplant in Adult Relapsed Acute Myeloid Leukemia (AML) Patients 311
Molecular expression of bone marrow angiogenic factors, cell-cell adhesion molecules and matrix-metallo-proteinases in plasmacellular disorders: A molecular panel to nvestigate disease progression 282
WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine 222
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion 170
Fibrin glue for refractory hemorrhagic cystitis after unrelated marrow, cord blood, and haploidentical hematopoietic stem cell transplantation 158
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia 157
Impaired nodal shrinkage and apoptosis define the independent adverse outcome of NOTCH1 mutated patients under ibrutinib therapy in chronic lymphocytic leukaemia 149
CT Images in Follicular Lymphoma: Changes after Treatment Are Predictive of Cardiac Toxicity in Patients Treated with Anthracycline-Based or R-B Regimens 139
18F-FDG PET/CT Radiomics for Predicting Therapy Response in Primary Mediastinal B-Cell Lymphoma: A Bi-Centric Pilot Study 131
Prophylaxis with Tixagevimab/Cilgavimab in chronic lymphocytic leukaemia, a case control study 130
Telemedicine as a Medical Examination Tool During the Covid-19 Emergency: The Experience of the Onco-Haematology Center of Tor Vergata Hospital in Rome 110
Serum Paraprotein Is Associated with Adverse Prognostic Factors and Outcome, across Different Subtypes of Mature B-Cell Malignancies—A Systematic Review 95
Pathogenetic mechanism of macular edema during a treatment with ibrutinib: a case presentation 91
Body composition in patients with follicular lymphoma: asso-ciations between changes in radiomic parameters in patients treated with R-CHOP-like and R-B regimens: LyRa 01F 91
Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study 89
Sustained Remission in Relapsed/Refractory Diffuse Large B Cell Lymphoma Following Glofitamab Discontinuation Due to JC Virus Reactivation: Balancing Efficacy and Infectious Risk 84
Complete remission induced by rituximab-lenalidomide, following CAR-T cell failure, is not associated with CAR-T cell re-expansion in the peripheral blood 78
Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia 76
Co-occurrence of angioimmunoblastic T-cell lymphoma and aggressive-refractory plasma-cell neoplasm: Two new cases and literature review 76
Association of [18F]-FDG PET/CT-Derived Radiomic Features with Clinical Outcomes and Genomic Profiles in Patients with Chronic Lymphocytic Leukemia 74
Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia 73
Coexistence of T-Large Granular Lymphocyte Leukemia and Peripheral T Cell Lymphoma-NOS with Indolent Behavior 70
The contribution of IL-10 and IL-6 as potential biomarkers for detecting central nervous system involvement in non-Hodgkin lymphomas 64
Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimens 61
COVID-19 vaccination: Evaluation of risk for protection failure in chronic lymphocytic leukemia patients 59
Vitamin D and non-Hodgkin lymphomas, trends from an Italian monocentric study 59
COVID-19 vaccination: evaluation of humoral and cellular immunity after the booster dose in chronic lymphocytic leukemia patients 55
Large clones of Clonal Hematopoiesis affect outcome in Mantle Cell Lymphoma: Results from The FIL MCL0208 Clinical Trial 54
Do age, fitness, and concomitant medications influence management and outcomes of patients with CLL treated with ibrutinib? 53
Lipegfilgrastim for primary prophylaxis of febrile neutropenia in patients treated for advanced-stage classical hodgkin lymphoma: successful outcomes from a multicenter cohort study 53
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 50
CD49d expression is included in a revised 4-factor model predicting outcome in patients with chronic lymphocytic leukemia treated with ibrutinib: A multicenter real-world experience 48
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort 39
null 3
Totale 20.500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.290
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.290
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022482 0 52 12 31 11 46 18 31 49 37 36 159
2022/2023815 71 69 63 104 47 150 83 71 91 9 41 16
2023/2024496 37 8 30 7 65 164 58 31 9 9 6 72
2024/20251.366 79 251 147 61 30 89 75 133 126 116 117 142
2025/20263.117 255 165 310 283 285 138 323 328 369 302 168 191
2026/2027300 167 133 0 0 0 0 0 0 0 0 0 0
Totale 20.500